We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
175 result(s) found, displaying 101 to 110
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Denosumab
-
Prescription medicine registrationActive ingredients: romiplostim (rbe).
-
Prescription medicine registrationActive ingredients: romosozumab.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for evolocumab
-
-
Prescription medicine registrationActive ingredients: trastuzumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REPATHA evolocumab (rch) 140 mg/mL injection solution syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BLINCYTO blinatumomab (rch) 38.5 microgram powder for injection vial with Intravenous (IV) solution stabiliser.
-
Prescription medicine registrationActive ingredients: evolocumab.